Investing

Adicet Bio : ACET

ACET

Stock Data

$8.20

$0.65 (8.61%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Adicet Bio Inc is a pioneering biotechnology firm based in Boston, Massachusetts, focused on developing innovative cancer treatments. It specializes in creating allogeneic gamma delta T cell therapies, a cutting-edge approach that aims to improve the body's immune response against tumors. The company's flagship product, ADI-001, is currently undergoing clinical trials for non-Hodgkin’s lymphoma. Additionally, Adicet Bio is working on other promising therapies, including ADI-002 for solid tumors and ADI-925, which targets tumor stress ligands for enhanced cancer targeting.

All Adicet Bio Articles

1 Article

Trey Thoelcke | Feb 5, 2024 at 12:09 PM EST

Insider Buying at These Biotechs Is Huge

As January wound to a close, beneficial owners, executives, and other insiders took advantage of public offerings of stock at…